Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: Final 3-year follow-up of the randomized evaluation of sirolimus-eluting versus everolimus-eluting stent trial

Circulation: Cardiovascular Interventions

Volumn 7, Issue 3, 2014, Pages 343-354

  Shiomi, Hiroki ^a   Kozuma, Ken ^b   Morimoto, Takeshi ^c   Igarashi, Keiichi ^d   Kadota, Kazushige ^e   Tanabe, Kengo ^f   Morino, Yoshihiro ^g   Akasaka, Takashi ^h   Abe, Mitsuru ⁱ   Suwa, Satoru ^j   Muramatsu, Toshiya ^k   Kobayashi, Masakazu ^l   Dai, Kazuoki ^m   Nakao, Koichi ⁿ   Uematsu, Masaaki ^o   Tarutani, Yasuhiro ^p   Fujii, Kenshi ^q   Simonton, Charles A ^r   Kimura, Takeshi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY HOSPITAL   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d Hokkaido Social Insurance Hospital   (Japan)

^e KURASHIKI CENTRAL HOSPITAL   (Japan)

^f MITSUI MEMORIAL HOSPITAL   (Japan)

^g IWATE UNIVERSITY   (Japan)

^h WAKAYAMA MEDICAL UNIVERSITY HOSPITAL   (Japan)

ⁱ NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^j JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^k SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

^l HAMAMATSU MEDICAL CENTER   (Japan)

^m HIROSHIMA CITY HOSPITAL   (Japan)

ⁿ SAISEIKAI KUMAMOTO HOSPITAL   (Japan)

^o KANSAI ROSAI HOSPITAL   (Japan)

^p Okamura Memorial Hospital   (Japan)

^q Sakurabashi Watanabe Hospital   (Japan)

^r ABBOTT VASCULAR   (United States)

more..

Author keywords

Coronary restenosis; Thrombosis

Indexed keywords

EVEROLIMUS; RAPAMYCIN;

AGED; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS; TREATMENT OUTCOME;

AGED; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; SIROLIMUS; THROMBOSIS; TREATMENT OUTCOME;

EID: 84905829224     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.113.001322     Document Type: Article

References (17)

1. Kimura T, Morimoto T, Natsuaki M, Shiomi H, Igarashi K, Kadota K, Tanabe K, Morino Y, Akasaka T, Takatsu Y, Nishikawa H, Yamamoto Y, Nakagawa Y, Hayashi Y, Iwabuchi M, Umeda H, Kawai K, Okada H, Kimura K, Simonton CA, Kozuma K; RESET Investigators. Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET). Circulation. 2012;126:1225-1236.
2. Byrne RA, Kastrati A, Massberg S, Wieczorek A, Laugwitz K-L, Hadamitzky M, Schulz S, Pache J, Fusaro M, Hausleiter J, Schömig A, Mehilli J. Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus-versus sirolimus-eluting stents in patients with coronary artery disease. J Am Coll Cardiol. 2011;58:1325-1331.
3. Okkels Jensen L, Thayssen P, Hansen HS, Christiansen EH, Tilsted HH, Krusell LR, Villadsen AB, Junker A, Norregaard Hansen K, Kaltoft A, Maeng M, Pedersen KE, Kristensen SD, Botker HE, Ravkilde J, Sanchez R, Aaroe J, Madsen M, Sorensen HT, Thuesen L, Lassen JF. Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV). Circulation. 2012;125:1246-1255.
4. Räber L, Magro M, Stefanini GG, Kalesan B, van Domburg RT, Onuma Y, Wenaweser P, Daemen J, Meier B, Jüni P, Serruys PW, Windecker S. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study. Circulation. 2012;125:1110-1121.
5. Räber L, Jüni P, Nüesch E, Kalesan B, Wenaweser P, Moschovitis A, Khattab AA, Bahlo M, Togni M, Cook S, Vogel R, Seiler C, Meier B, Windecker S. Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularization. J Am Coll Cardiol. 2011;57:2143-2151.
6. Palmerini T, Biondi-Zoccai G, Della Riva D, Stettler C, Sangiorgi D, D'Ascenzo F, Kimura T, Briguori C, Sabatè M, Kim HS, De Waha A, Kedhi E, Smits PC, Kaiser C, Sardella G, Marullo A, Kirtane AJ, Leon MB, Stone GW. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet. 2012;379:1393-1402.
7. Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh J-W, Kim H-S, Park S-J, Kastrati A, de Waha A, Krishnan P, Moreno P, Sweeny J, Kim MC, Suleman J, Pyo R, Wiley J, Kovacic J, Kini AS, Dangas GD. Impact of the everolimus-eluting stent on stent thrombosis. J Am Coll Cardiol. 2011;58:1569-1577.
8. Jensen LO, Thayssen P, Christiansen EH, Tilsted HH, Maeng M, Hansen KN, Kaltoft A, Hansen HS, Bøtker HE, Krusell LR, Ravkilde J, Madsen M, Thuesen L, Lassen JF. 2-year patient-related versus stent-related outcomes. J Am Coll Cardiol. 2012;60:1140-1147.
9. Kaiser C, Galatius S, Erne P, Eberli F, Alber H, Rickli H, Pedrazzini G, Hornig B, Bertel O, Bonetti P, De Servi S, Brunner-La Rocca HP, Ricard I, Pfsterer M. Drug-eluting versus bare-metal stents in large coronary arteries. N Engl J Med. 2010;363:2310-2319.
10. Kozuma K, Kimura T, Kadota K, Suwa S, Kimura K, Iwabuchi M, Kawai K, Miyazawa A, Kawamura M, Nakao K, Asano R, Yamamoto T, Suzuki N, Aoki J, Kyono H, Nakazawa G, Tanabe K, Morino Y, Igarashi K. Angiographic fndings of everolimus-eluting as compared to sirolimus-eluting stents: angiographic sub-study from the Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial (RESET). Cardiovasc Interv Ther. 2013;28:344-351.
11. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, Nishikawa H, Hiasa Y, Muramatsu T, Meguro T, Inoue N, Honda H, Hayashi Y, Miyazaki S, Oshima S, Honda T, Shiode N, Namura M, Sone T, Nobuyoshi M, Kita T, Mitsudo K. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009;119:987-995.
12. Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, Shiode N, Namura M, Sone T, Oshima S, Nishikawa H, Hiasa Y, Hayashi Y, Nobuyoshi M, Mitudo K. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: fve-year outcome of the j-Cypher Registry. Circulation. 2012;125:584-591.
13. Smits PC, Kedhi E, Royaards K-J, Joesoef KS, Wassing J, Rademaker-Havinga TAM, McFadden E. 2-year follow-up of a randomized controlled trial of everolimus-and paclitaxel-eluting stents for coronary revascular-ization in daily practice. J Am Coll Cardiol. 2011;58:11-18.
14. de Waha A, Cassese S, Park DW, Burzotta F, Byrne RA, Tada T, King LA, Park SJ, Schömig A, Kastrati A. Everolimus-eluting versus sirolimus-eluting stents: an updated meta-analysis of randomized trials. Clin Res Cardiol. 2012;101:461-467.
15. Park KW, Kang SH, Velders MA, Shin DH, Hahn S, Lim WH, Yang HM, Lee HY, Van Boven AJ, Hofma SH, Kang HJ, Koo BK, Oh BH, Park YB, Kandzari DE, Kim HS. Safety and effcacy of everolimus-versus sirolim-us-eluting stents: a systematic review and meta-analysis of 11 randomized trials. Am Heart J. 2013;165:241-250.e4.
16. Otsuka F, Vorpahl M, Nakano M, Foerst J, Newell JB, Sakakura K, Kutys R, Ladich E, Finn AV, Kolodgie FD, Virmani R. Pathology of second-generation everolimus-eluting stents versus frst-generation sirolimus-and paclitaxel-eluting stents in humans. Circulation. 2014;129:211-223.
17. Kotani J, Ikari Y, Kyo E, Nakamura M, Yokoi H, Furuno K, Inui H, Kozuma K. Five-year outcomes of Cypher™ coronary stent: report from J-PMS Study. Cardiovasc Interv Ther. 2012;27:63-71.